Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control

NCT: NCT06358755 · ACTIVE_NOT_RECRUITING

NCT IDNCT06358755
StatusACTIVE_NOT_RECRUITING
Start Date2024-07-12
Completion2027-01-31

Brief Summary

The purpose of the study is to investigate the combination effect of optical defocus and low dose atropine on myopia control in schoolchildren.

Frequently Asked Questions

What is Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control?

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control is a clinical trial registered under NCT06358755. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06358755?

The current status of NCT06358755 (Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control) is: ACTIVE_NOT_RECRUITING.

When did Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control start?

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control started on 2024-07-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑